Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.0T | 1.9T | 1.5T | 1.5T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 244.2B | 331.1B | 222.3B | 242.1B |
Other operating expenses | 109.8B | 146.3B | 132.0B | 93.1B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 458.1B | 441.0B | 423.3B | 415.8B |
Tax provision | 110.8B | 75.3B | 114.1B | 104.7B |
Net income | 347.3B | 365.8B | 309.2B | 311.0B |
Basic EPS | 19.8 | — | — | — |
Diluted EPS | 19.8 | — | — | — |
Basic average shares | 15.0B | — | — | — |
Diluted average shares | 15.0B | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -49.4B | — | — | — |
Preferred stock dividends | — | — | — | — |